Shared decision-making and satisfaction with care in patients with psoriasis: A population-based study in the United States - 10/10/23
Abstract |
Background |
Shared decision-making (SDM) is a critical component of the patient-physician relationship. Although SDM has been reported to improve patient knowledge in other fields, it is still relatively unknown in dermatology.
Objective |
To determine the association between SDM and satisfaction with care among patients with psoriasis.
Methods |
Cross-sectional study using data from the 2014 to 2017 and 2019 Medical Expenditure Panel Survey.
Results |
A weighted total of 3,715,027 patients with psoriasis were identified. The average SDM score was 3.6 (of 4), and the average satisfaction with care score was 8.6 (of 10). Approximately 42% of the cohort reported having a high SDM (score, ≥3.9). Patients who had high SDM had, on average, 85% higher satisfaction with care (P < .001) after adjusting for covariates.
Limitations |
The results of our study should be interpreted within the context of the Medical Expenditure Panel Survey database. The ability to measure SDM was limited by the 7 items from Medical Expenditure Panel Survey, which may not fully capture active participation in shared decision-making.
Conclusion |
A majority of patients with psoriasis are not participating in highly SDM. It is important to construct a framework for carrying out SDM efficiently to enhance physician-patient communication and improve patient outcomes.
Il testo completo di questo articolo è disponibile in PDF.Key words : MEPS, Medical Panel Expenditure Survey, patient satisfaction, psoriasis, shared decision-making, satisfaction with care, United States
Abbreviations used : aOR, ICD, MEPS, SDM
Mappa
| Funding sources: Supported by the National Psoriasis Foundation. |
|
| IRB approval status: Not applicable. |
Vol 89 - N° 5
P. 920-926 - novembre 2023 Ritorno al numero
Articolo precedente
- A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areata
- Cheng Zhou, Xiumin Yang, Bin Yang, Guofu Yan, Xiuqin Dong, Yangfeng Ding, Weixin Fan, Linfeng Li, Dingquan Yang, Hong Fang, Chao Ji, Hao Cheng, Shoumin Zhang, Aik Han Goh, Rongjun Liu, Xiaoyu Gu, Zaili Weng, Peter Foley, Rodney Sinclair, Jianzhong Zhang
- Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trials
- Linda Stein Gold, Edward Lain, James Q. Del Rosso, Michael Gold, Zoe D. Draelos, Lawrence F. Eichenfield, Neil Sadick, William P. Werschler, Melinda J. Gooderham, Mary Lupo
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?